New Congo Ebola Spreads Like Lightning - 49 Dead, 2157 Possibly Infected (Video)
The Congolese government’s health ministry released an update as to its Ebola situation late Saturday evening, which is even scarier than the numbers released by the WHO on Friday (see our released coverage)
The number of confirmed deaths has jumped from 44 to 49 in two days whilst the number of probable infection contacts from 1,500 to a whopping 2,157. Given the precarious situation and the scarce health workers in the field, most local reporters admitted the true number is probably higher.
https://www.thegoldwater.com/news/34460-New-Congo-Ebola-Spreads-Like-Lightning-49-Dead-2157-Possibly-Infected-Video
NOTE: Just to be clear where ebola came from
Why does the CDC own a patent on Ebola 'invention?'
Harvesting Ebola from victims to file patents
From the patent description on the EboBun virus, we know that the U.S. government:
1) Extracts Ebola viruses from patients.
2) Claims to have "invented" that virus.
3) Files for monopoly patent protection on the virus.
To understand why this is happening, you have to first understand what a patent really is and why it exists. A patent is a government-enforced monopoly that is exclusively granted to persons or organizations. It allows that person or organization to exclusively profit from the "invention" or deny others the ability to exploit the invention for their own profit.
It brings up the obvious question here: Why would the U.S. government claim to have "invented" Ebola and then claim an exclusively monopoly over its ownership?
U.S. Government claims exclusive ownership over its "invention" of Ebola
The "SUMMARY OF THE INVENTION" section of the patent document also clearly claims that the U.S. government is claiming "ownership" over all Ebola viruses that share as little as 70% similarity with the Ebola it "invented":
…invention relates to the isolated EboBun virus that morphologically and phylogenetically relates to known members filoviridae… In another aspect, the invention provides an isolated hEbola EboBun virus comprising a nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of: a) a nucleotide sequence set forth in SEQ ID NO: 1; b) a nucleotide sequence that hybridizes to the sequence set forth in SEQ ID NO: 1 under stringent conditions; and c) a nucleotide sequence that has at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% identity to the SEQ ID NO:
-
In another aspect, the invention provides the complete genomic sequence of the hEbola virus EboBun.
THERE PLANS
Ebola vaccines and propagation
The CDC patent goes on to explain it specifically claims patent protection on a method for propagating the Ebola virus in host cells as well as treating infected hosts with vaccines:
In another aspect, the invention provides a method for propagating the hEbola virus in host cells comprising infecting the host cells with the inventive isolated hEbola virus described above, culturing the host cells to allow the virus to multiply, and harvesting the resulting virions.
In another aspect, the invention provides vaccine preparations, comprising the inventive hEbola virus, including recombinant and chimeric forms of the virus, nucleic acid molecules comprised by the virus, or protein subunits of the virus. The invention also provides a vaccine formulation comprising a therapeutically or prophylactically effective amount of the inventive hEbola virus described above, and a pharmaceutically acceptable carrier.
https://www.naturalnews.com/046290_Ebola_patent_vaccines_profit_motive.html